Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Cantor Fitzgerald
McKesson
Cerilliant
Novartis
Federal Trade Commission
Merck
Medtronic
Harvard Business School

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021673

« Back to Dashboard

NDA 021673 describes CLOLAR, which is a drug marketed by Genzyme and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the CLOLAR profile page.

The generic ingredient in CLOLAR is clofarabine. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clofarabine profile page.
Summary for 021673
Tradename:CLOLAR
Applicant:Genzyme
Ingredient:clofarabine
Patents:1
Pharmacology for NDA: 021673
Suppliers and Packaging for NDA: 021673
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOLAR clofarabine INJECTABLE;IV (INFUSION) 021673 NDA sanofi-aventis U.S. LLC 0024-5860 0024-5860-01 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) > 20 mL in 1 VIAL, SINGLE-USE
CLOLAR clofarabine INJECTABLE;IV (INFUSION) 021673 NDA sanofi-aventis U.S. LLC 0024-5917 0024-5917-01 1 VIAL, SINGLE-USE in 1 BOX (0024-5917-01) > 20 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)Strength20MG/20ML (1MG/ML)
Approval Date:Dec 28, 2004TE:APRLD:Yes
Patent:➤ SubscribePatent Expiration:Jul 14, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021673

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme CLOLAR clofarabine INJECTABLE;IV (INFUSION) 021673-001 Dec 28, 2004 ➤ Subscribe ➤ Subscribe
Genzyme CLOLAR clofarabine INJECTABLE;IV (INFUSION) 021673-001 Dec 28, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Fish and Richardson
UBS
Dow
Federal Trade Commission
QuintilesIMS
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot